| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
GE KH MA MD TN |
| (30) |
Priority: |
13.12.2023 US 202363609553 P 30.01.2024 US 202463626846 P 06.03.2024 US 202463562084 P 19.03.2024 US 202463567152 P 26.03.2024 US 202463570024 P 22.04.2024 US 202463637221 P 29.04.2024 US 202463639863 P 15.07.2024 US 202463671415 P
|
| (71) |
Applicants: |
|
- Renagade Therapeutics Management Inc.
Watertown, MA 02472 (US)
- Orna Therapeutics, Inc.
Watertown, MA 02472 (US)
|
|
| (72) |
Inventors: |
|
- JAYARAMAN, Muthusamy
Watertown, Massachusetts 02472 (US)
- SANKARAN, Ganapathy Subramanian
Watertown, Massachusetts 02472 (US)
- SMITH, David Townsend
Watertown, Massachusetts 02472 (US)
- RHYM, Luke Hyunsik
Watertown, Massachusetts 02472 (US)
- NARAYANAN, Elisabeth
Watertown, Massachusetts 02472 (US)
- JOHN, Shinu
Watertown, Massachusetts 02472 (US)
- WANG, Yinghua
Watertown, Massachusetts 02472 (US)
- KOSAKOWSKA, Karolina Anna
Watertown, Massachusetts 02472 (US)
- BOLEN, Joseph
Watertown, Massachusetts 02472 (US)
- PRESNYAK, Vladimir
Watertown, Massachusetts 02472 (US)
- PEPIN, Christopher Stephen
Watertown, Massachusetts 02472 (US)
|
| (74) |
Representative: Goodwin Procter (UK) LLP |
|
Sancroft, 10-15 Newgate Street EC1A 7AZ / London EC1A 7AZ / London (GB) |
|